Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Haemorrhagic bullous lesions indicating cutaneous light chain amyloidosis with smoldering myeloma.

Gambichler T, Doerler M, Nöpel-Dünnebacke S, Matschke J, Bräsen JH, Linke RP, Susok L.

J Eur Acad Dermatol Venereol. 2019 Aug 7. doi: 10.1111/jdv.15844. [Epub ahead of print]

PMID:
31390676
2.

Unilaterally Enlarged Mandibular Foramina and Canal Associated With Hyperplastic Lymphatic Tissue of Inferior Alveolar Nerve: Case Report and Short Literature Survey.

Friedrich RE, Matschke J, Wilczak W.

Anticancer Res. 2019 Aug;39(8):3991-4002. doi: 10.21873/anticanres.13554. Review.

PMID:
31366480
3.

Complement 3+-astrocytes are highly abundant in prion diseases, but their abolishment led to an accelerated disease course and early dysregulation of microglia.

Hartmann K, Sepulveda-Falla D, Rose IVL, Madore C, Muth C, Matschke J, Butovsky O, Liddelow S, Glatzel M, Krasemann S.

Acta Neuropathol Commun. 2019 May 22;7(1):83. doi: 10.1186/s40478-019-0735-1.

4.

DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development.

Binder H, Willscher E, Loeffler-Wirth H, Hopp L, Jones DTW, Pfister SM, Kreuz M, Gramatzki D, Fortenbacher E, Hentschel B, Tatagiba M, Herrlinger U, Vatter H, Matschke J, Westphal M, Krex D, Schackert G, Tonn JC, Schlegel U, Steiger HJ, Wick W, Weber RG, Weller M, Loeffler M.

Acta Neuropathol Commun. 2019 Apr 25;7(1):59. doi: 10.1186/s40478-019-0704-8.

5.

Relapse rates and long-term outcome in primary angiitis of the central nervous system.

Schuster S, Ozga AK, Stellmann JP, Deb-Chatterji M, Häußler V, Matschke J, Gerloff C, Thomalla G, Magnus T.

J Neurol. 2019 Jun;266(6):1481-1489. doi: 10.1007/s00415-019-09285-1. Epub 2019 Mar 23.

PMID:
30904954
6.

Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanoma.

Shannan B, Matschke J, Chauvistré H, Vogel F, Klein D, Meier F, Westphal D, Bruns J, Rauschenberg R, Utikal J, Forschner A, Berking C, Terheyden P, Dabrowski E, Gutzmer R, Rafei-Shamsabadi D, Meiss F, Heinzerling L, Zimmer L, Livingstone E, Váraljai R, Hoewner A, Horn S, Klode J, Stuschke M, Scheffler B, Marchetto A, Sannino G, Grünewald TGP, Schadendorf D, Jendrossek V, Roesch A.

Eur J Cancer. 2019 Mar;109:137-153. doi: 10.1016/j.ejca.2018.12.024. Epub 2019 Feb 2.

PMID:
30721788
7.

[Muscular polyarteritis nodosa-a case-based review].

Krusche M, Ruffer N, Kubacki T, Matschke J, Kötter I.

Z Rheumatol. 2019 Mar;78(2):173-179. doi: 10.1007/s00393-019-0595-x. German.

PMID:
30694359
8.

Rheumatoid meningitis: A rare cause of aseptic meningitis with frequently stroke-like episodes.

Schuster S, Braass H, Iking-Konert C, Schnoor U, Matschke J, Gerloff C, Thomalla G, Magnus T.

Neurol Clin Pract. 2018 Oct;8(5):451-455. doi: 10.1212/CPJ.0000000000000504.

PMID:
30564500
9.

Seizures as presenting symptom in patients with glioblastoma.

Dührsen L, Sauvigny T, Ricklefs FL, Mende KC, Schaper M, Matschke J, Goebell E, Westphal M, Martens T.

Epilepsia. 2019 Jan;60(1):149-154. doi: 10.1111/epi.14615. Epub 2018 Dec 9.

PMID:
30536819
10.

Oxidative stress: the lowest common denominator of multiple diseases.

Matschke V, Theiss C, Matschke J.

Neural Regen Res. 2019 Feb;14(2):238-241. doi: 10.4103/1673-5374.244780. Review.

11.

The role of frameless stereotactic biopsy in contemporary neuro-oncology: molecular specifications and diagnostic yield in biopsied glioma patients.

Mader MM, Rotermund R, Martens T, Westphal M, Matschke J, Abboud T.

J Neurooncol. 2019 Jan;141(1):183-194. doi: 10.1007/s11060-018-03024-8. Epub 2018 Nov 2.

PMID:
30390175
12.

Distinct microglia profile in Creutzfeldt-Jakob disease and Alzheimer's disease is independent of disease kinetics.

Krbot K, Hermann P, Skorić MK, Zerr I, Sepulveda-Falla D, Goebel S, Matschke J, Krasemann S, Glatzel M.

Neuropathology. 2018 Dec;38(6):591-600. doi: 10.1111/neup.12517. Epub 2018 Oct 15.

PMID:
30318820
13.

Targeting SLC25A10 alleviates improved antioxidant capacity and associated radioresistance of cancer cells induced by chronic-cycling hypoxia.

Hlouschek J, Ritter V, Wirsdörfer F, Klein D, Jendrossek V, Matschke J.

Cancer Lett. 2018 Dec 28;439:24-38. doi: 10.1016/j.canlet.2018.09.002. Epub 2018 Sep 8.

PMID:
30205167
14.

Non-secreting pituitary tumours characterised by enhanced expression of YAP/TAZ.

Xekouki P, Lodge EJ, Matschke J, Santambrogio A, Apps JR, Sharif A, Jacques TS, Aylwin S, Prevot V, Li R, Flitsch J, Bornstein SR, Theodoropoulou M, Andoniadou CL.

Endocr Relat Cancer. 2019 Jan 1;26(1):215-225. doi: 10.1530/ERC-18-0330.

15.

The secreted glycolytic enzyme GPI/AMF stimulates glioblastoma cell migration and invasion in an autocrine fashion but can have anti-proliferative effects.

Kathagen-Buhmann A, Maire CL, Weller J, Schulte A, Matschke J, Holz M, Ligon KL, Glatzel M, Westphal M, Lamszus K.

Neuro Oncol. 2018 Nov 12;20(12):1594-1605. doi: 10.1093/neuonc/noy117.

PMID:
30053149
16.

A significant proportion of patients with primary central nervous system lymphoma harbor clonal bone marrow B-cells.

Brandt A, Matschke J, Fehrle W, von Wenserski L, Bokemeyer C, Illerhaus G, Binder M.

Leuk Lymphoma. 2019 Feb;60(2):334-340. doi: 10.1080/10428194.2018.1482538. Epub 2018 Jul 22.

PMID:
30033830
17.

Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance.

Hermann P, Laux M, Glatzel M, Matschke J, Knipper T, Goebel S, Treig J, Schulz-Schaeffer W, Cramm M, Schmitz M, Zerr I.

Neurology. 2018 Jul 24;91(4):e331-e338. doi: 10.1212/WNL.0000000000005860. Epub 2018 Jun 22.

PMID:
29934424
18.
19.

Tectal gliomas: assessment of malignant progression, clinical management, and quality of life in a supposedly benign neoplasm.

Mohme M, Fritzsche FS, Mende KC, Matschke J, Löbel U, Kammler G, Westphal M, Emami P, Martens T.

Neurosurg Focus. 2018 Jun;44(6):E15. doi: 10.3171/2018.3.FOCUS1850.

PMID:
29852760
20.

Alterations in the brain interactome of the intrinsically disordered N-terminal domain of the cellular prion protein (PrPC) in Alzheimer's disease.

Ulbrich S, Janning P, Seidel R, Matschke J, Gonsberg A, Jung S, Glatzel M, Engelhard M, Winklhofer KF, Tatzelt J.

PLoS One. 2018 May 23;13(5):e0197659. doi: 10.1371/journal.pone.0197659. eCollection 2018.

21.

Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial.

Dührsen U, Müller S, Hertenstein B, Thomssen H, Kotzerke J, Mesters R, Berdel WE, Franzius C, Kroschinsky F, Weckesser M, Kofahl-Krause D, Bengel FM, Dürig J, Matschke J, Schmitz C, Pöppel T, Ose C, Brinkmann M, La Rosée P, Freesmeyer M, Hertel A, Höffkes HG, Behringer D, Prange-Krex G, Wilop S, Krohn T, Holzinger J, Griesshammer M, Giagounidis A, Raghavachar A, Maschmeyer G, Brink I, Bernhard H, Haberkorn U, Gaska T, Kurch L, van Assema DME, Klapper W, Hoelzer D, Geworski L, Jöckel KH, Scherag A, Bockisch A, Rekowski J, Hüttmann A; PETAL Trial Investigators.

J Clin Oncol. 2018 Jul 10;36(20):2024-2034. doi: 10.1200/JCO.2017.76.8093. Epub 2018 May 11.

PMID:
29750632
22.

Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes.

Mohme M, Schliffke S, Maire CL, Rünger A, Glau L, Mende KC, Matschke J, Gehbauer C, Akyüz N, Zapf S, Holz M, Schaper M, Martens T, Schmidt NO, Peine S, Westphal M, Binder M, Tolosa E, Lamszus K.

Clin Cancer Res. 2018 Sep 1;24(17):4187-4200. doi: 10.1158/1078-0432.CCR-17-2617. Epub 2018 Feb 14.

PMID:
29444930
23.

No difference in the prevalence of Alzheimer-type neurodegenerative changes in the brains of suicides when compared with controls: an explorative neuropathologic study.

Matschke J, Sehner S, Gallinat J, Siegers J, Murroni M, Püschel K, Glatzel M.

Eur Arch Psychiatry Clin Neurosci. 2018 Aug;268(5):509-517. doi: 10.1007/s00406-018-0876-4. Epub 2018 Jan 30.

PMID:
29383449
24.

Neuroradiologic Characteristics of Primary Angiitis of the Central Nervous System According to the Affected Vessel Size.

Thaler C, Kaufmann-Bühler AK, Gansukh T, Gansukh A, Schuster S, Bachmann H, Thomalla G, Magnus T, Matschke J, Fiehler J, Siemonsen S.

Clin Neuroradiol. 2019 Mar;29(1):37-44. doi: 10.1007/s00062-017-0622-8. Epub 2017 Sep 5.

PMID:
28875326
25.

Impact of focal cortical dysplasia Type IIIa on seizure outcome following anterior mesial temporal lobe resection for the treatment of epilepsy.

Dührsen L, Sauvigny T, House PM, Stodieck S, Holst B, Matschke J, Schön G, Westphal M, Martens T.

J Neurosurg. 2018 Jun;128(6):1668-1673. doi: 10.3171/2017.2.JNS161295. Epub 2017 Jul 28.

PMID:
28753112
26.

Subtypes of primary angiitis of the CNS identified by MRI patterns reflect the size of affected vessels.

Schuster S, Bachmann H, Thom V, Kaufmann-Buehler AK, Matschke J, Siemonsen S, Glatzel M, Fiehler J, Gerloff C, Magnus T, Thomalla G.

J Neurol Neurosurg Psychiatry. 2017 Sep;88(9):749-755. doi: 10.1136/jnnp-2017-315691. Epub 2017 Jul 13.

PMID:
28705900
27.

Pituicytoma-An outlook on possible targeted therapies.

Mende KC, Matschke J, Burkhardt T, Saeger W, Buslei R, Buchfelder M, Fahlbusch R, Westphal M, Flitsch J.

CNS Neurosci Ther. 2017 Jul;23(7):620-626. doi: 10.1111/cns.12709. Epub 2017 May 28.

28.

Diagnostic red flags: steroid-treated malignant CNS lymphoma mimicking autoimmune inflammatory demyelination.

Barrantes-Freer A, Engel AS, Rodríguez-Villagra OA, Winkler A, Bergmann M, Mawrin C, Kuempfel T, Pellkofer H, Metz I, Bleckmann A, Hernández-Durán S, Schippling S, Rushing EJ, Frank S, Glatzel M, Matschke J, Hartmann C, Reifenberger G, Müller W, Schildhaus HU, Brück W, Stadelmann C.

Brain Pathol. 2018 Mar;28(2):225-233. doi: 10.1111/bpa.12496. Epub 2017 Apr 6.

PMID:
28213912
29.

Surgical treatment and outcome of TSH-producing pituitary adenomas.

Rotermund R, Riedel N, Burkhardt T, Matschke J, Schmidt NO, Aberle J, Flitsch J.

Acta Neurochir (Wien). 2017 Jul;159(7):1219-1226. doi: 10.1007/s00701-017-3105-4. Epub 2017 Feb 15.

PMID:
28204898
30.

Role of HYAL1 expression in primary breast cancer in the formation of brain metastases.

Witzel I, Marx AK, Müller V, Wikman H, Matschke J, Schumacher U, Stürken C, Prehm P, Laakmann E, Schmalfeldt B, Milde-Langosch K, Oliveira-Ferrer L.

Breast Cancer Res Treat. 2017 Apr;162(3):427-438. doi: 10.1007/s10549-017-4135-6. Epub 2017 Feb 6.

PMID:
28168629
31.

A 55-Year-Old Woman with Year-Long Headache and Dizziness.

Dührsen L, Matschke J, Westphal M.

Brain Pathol. 2017 Jan;27(1):111-112. doi: 10.1111/bpa.12463. No abstract available.

PMID:
28032421
32.

PTEN mediates the cross talk between breast and glial cells in brain metastases leading to rapid disease progression.

Hohensee I, Chuang HN, Grottke A, Werner S, Schulte A, Horn S, Lamszus K, Bartkowiak K, Witzel I, Westphal M, Matschke J, Glatzel M, Jücker M, Pukrop T, Pantel K, Wikman H.

Oncotarget. 2017 Jan 24;8(4):6155-6168. doi: 10.18632/oncotarget.14047.

33.

The Natural Plant Product Rottlerin Activates Kv7.1/KCNE1 Channels.

Matschke V, Piccini I, Schubert J, Wrobel E, Lang F, Matschke J, Amedonu E, Meuth SG, Strünker T, Strutz-Seebohm N, Greber B, Scherkenbeck J, Seebohm G.

Cell Physiol Biochem. 2016;40(6):1549-1558. doi: 10.1159/000453205. Epub 2016 Dec 21.

34.

Amyloid-β Precursor Protein Modulates the Sorting of Testican-1 and Contributes to Its Accumulation in Brain Tissue and Cerebrospinal Fluid from Patients with Alzheimer Disease.

Barrera-Ocampo A, Arlt S, Matschke J, Hartmann U, Puig B, Ferrer I, Zürbig P, Glatzel M, Sepulveda-Falla D, Jahn H.

J Neuropathol Exp Neurol. 2016 Sep;75(9):903-16. doi: 10.1093/jnen/nlw065. Epub 2016 Aug 2.

35.

Aromatase Expression in the Hippocampus of AD Patients and 5xFAD Mice.

Prange-Kiel J, Dudzinski DA, Pröls F, Glatzel M, Matschke J, Rune GM.

Neural Plast. 2016;2016:9802086. doi: 10.1155/2016/9802086. Epub 2016 May 19.

36.

Role of SGK1 for fatty acid uptake, cell survival and radioresistance of NCI-H460 lung cancer cells exposed to acute or chronic cycling severe hypoxia.

Matschke J, Wiebeck E, Hurst S, Rudner J, Jendrossek V.

Radiat Oncol. 2016 Jun 1;11:75. doi: 10.1186/s13014-016-0647-1.

37.

Secretory Meningiomas: Increased Prevalence of Seizures Secondary to Edema Formation in a Rare Histologic Subtype.

Mohme M, Emami P, Regelsberger J, Matschke J, Lamszus K, Westphal M, Eicker SO.

World Neurosurg. 2016 Aug;92:418-425. doi: 10.1016/j.wneu.2016.05.046. Epub 2016 May 27.

PMID:
27241088
38.

A Randomized Trial of Daily Prednisone versus Pulsed Dexamethasone in Treatment-Naïve Adult Patients with Immune Thrombocytopenia: EIS 2002 Study.

Matschke J, Müller-Beissenhirtz H, Novotny J, Vester I, Hertenstein B, Eisele L, Lax H, Ose C, Dührsen U.

Acta Haematol. 2016;136(2):101-7. doi: 10.1159/000445420. Epub 2016 May 19.

PMID:
27189086
39.

Early-onset parkinsonism due to compound heterozygous POLG mutations.

Rempe T, Kuhlenbäumer G, Krüger S, Biskup S, Matschke J, Hagel C, Deuschl G, van Eimeren T.

Parkinsonism Relat Disord. 2016 Aug;29:135-7. doi: 10.1016/j.parkreldis.2016.04.020. Epub 2016 Apr 27. No abstract available.

PMID:
27185166
40.

Meninigiomas of the Craniocervical Junction--A Distinctive Subgroup of Meningiomas.

Dührsen L, Emami P, Matschke J, Abboud T, Westphal M, Regelsberger J.

PLoS One. 2016 Apr 12;11(4):e0153405. doi: 10.1371/journal.pone.0153405. eCollection 2016.

41.

Sexual Activity as a Risk Factor for the Spontaneous Rupture of Cerebral Aneurysms.

Blanke-Roeser C, Matschke J, Püschel K.

Am J Forensic Med Pathol. 2016 Jun;37(2):70-3. doi: 10.1097/PAF.0000000000000231.

PMID:
27043460
42.

Targeted Inhibition of Glutamine-Dependent Glutathione Metabolism Overcomes Death Resistance Induced by Chronic Cycling Hypoxia.

Matschke J, Riffkin H, Klein D, Handrick R, Lüdemann L, Metzen E, Shlomi T, Stuschke M, Jendrossek V.

Antioxid Redox Signal. 2016 Jul 10;25(2):89-107. doi: 10.1089/ars.2015.6589. Epub 2016 May 9.

PMID:
27021152
43.

Secretory Meningiomas: Characteristic Features and Clinical Management of a Unique Subgroup.

Mohme M, Emami P, Matschke J, Regelsberger J, Westphal M, Eicker SO.

Neurosurg Clin N Am. 2016 Apr;27(2):181-7. doi: 10.1016/j.nec.2015.11.001. Epub 2016 Feb 19. Review.

PMID:
27012382
44.

Does usage of a parachute in contrast to free fall prevent major trauma?: a prospective randomised-controlled trial in rag dolls.

Czorlich P, Burkhardt T, Buhk JH, Matschke J, Dreimann M, Schmidt NO, Eicker SO.

Eur Spine J. 2016 May;25(5):1349-1354. doi: 10.1007/s00586-016-4381-z. Epub 2016 Jan 14.

PMID:
26769034
45.

A 19-Year-Old Male with an Intraventricular Tumor.

Krajewski KL, Matschke J, Humke N, Börm W, Westphal M, Schmidt NO.

Brain Pathol. 2015 Sep;25(5):657-8. doi: 10.1111/bpa.12287. No abstract available.

PMID:
26276031
46.

Printed peptide arrays identify prognostic TNC serumantibodies in glioblastoma patients.

Mock A, Warta R, Geisenberger C, Bischoff R, Schulte A, Lamszus K, Stadler V, Felgenhauer T, Schichor C, Schwartz C, Matschke J, Jungk C, Ahmadi R, Sahm F, Capper D, Glass R, Tonn JC, Westphal M, von Deimling A, Unterberg A, Bermejo JL, Herold-Mende C.

Oncotarget. 2015 May 30;6(15):13579-90.

47.

Long-term vestibulocochlear functional outcome following retro-sigmoid approach to resection of vestibular schwannoma.

Abboud T, Regelsberger J, Matschke J, Jowett N, Westphal M, Dalchow C.

Eur Arch Otorhinolaryngol. 2016 Mar;273(3):719-25. doi: 10.1007/s00405-015-3561-5. Epub 2015 Feb 21.

PMID:
25700833
48.

No reactivation of JCV and CMV infections in the temporal cortex and cerebellum of sporadic Creutzfeldt-Jakob disease patients.

Löffler J, Krasemann S, Zerr I, Matschke J, Glatzel M.

Am J Neurodegener Dis. 2014 Dec 5;3(3):152-7. eCollection 2014.

49.

Inhibition of intracerebral glioblastoma growth by targeting the insulin-like growth factor 1 receptor involves different context-dependent mechanisms.

Zamykal M, Martens T, Matschke J, Günther HS, Kathagen A, Schulte A, Peters R, Westphal M, Lamszus K.

Neuro Oncol. 2015 Aug;17(8):1076-85. doi: 10.1093/neuonc/nou344. Epub 2014 Dec 27.

50.

Erratum to: Encephalopathy and death in infants with abusive head trauma is due to hypoxic-ischemic injury following local brain trauma to vital brainstem centers.

Matschke J, Büttner A, Bergmann M, Hagel C, Püschel K, Glatzel M.

Int J Legal Med. 2015 Jan;129(1):115-6. doi: 10.1007/s00414-014-1087-9. No abstract available.

PMID:
25239222

Supplemental Content

Loading ...
Support Center